We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $113B
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
+3%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+524.93%
AUM
$96.6B
AUM Growth
-$813M
Cap. Flow
-$2.51B
Cap. Flow %
-2.6%
Top 10 Hldgs %
13.1%
Holding
822
New
68
Increased
222
Reduced
455
Closed
69

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$743M
2
GILD icon
Gilead Sciences
GILD
+$513M
3
LH icon
Labcorp
LH
+$508M
4
CI icon
Cigna
CI
+$348M
5
EPAM icon
EPAM Systems
EPAM
+$304M

Sector Composition

Rank Sector Weight
1 Financials 20.9%
2 Technology 15.16%
3 Industrials 14.83%
4 Healthcare 12.72%
5 Consumer Discretionary 10.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPG icon
76
Simon Property Group
SPG
$71.7B
$445M 0.46%
2,403,041
-43,231
-2% -$7.85M
FTI icon
77
TechnipFMC
FTI
$30.1B
$434M 0.45%
9,736,346
-125,636
-1% -$5.31M
BAC icon
78
Bank of America
BAC
$448B
$433M 0.45%
7,873,240
-207,223
-3% -$11M
EWBC icon
79
East-West Bancorp
EWBC
$18.6B
$431M 0.45%
3,838,729
-36,008
-0.9% -$3.82M
WAB icon
80
Wabtec
WAB
$50.3B
$430M 0.45%
2,009,616
-295,216
-13% -$60.7M
GEN icon
81
Gen Digital
GEN
$17.7B
$425M 0.44%
15,644,289
+1,954,712
+14% +$52.6M
FCX icon
82
Freeport-McMoran
FCX
$93.6B
$405M 0.42%
7,916,348
+3,395,264
+75% +$147M
RNR icon
83
RenaissanceRe
RNR
$13.3B
$400M 0.41%
1,423,483
+128,245
+10% +$33.7M
AZN icon
84
AstraZeneca
AZN
$244B
$389M 0.4%
2,114,896
-508,829
-19% -$89.2M
GEHC icon
85
GE HealthCare
GEHC
$33.3B
$382M 0.4%
4,659,562
+830,626
+22% +$64.7M
EBAY icon
86
eBay
EBAY
$46.5B
$380M 0.39%
4,361,843
-79,495
-2% -$6.88M
SSNC icon
87
SS&C Technologies
SSNC
$19.3B
$375M 0.39%
4,285,669
-150,989
-3% -$12.9M
MAS icon
88
Masco
MAS
$14.7B
$364M 0.38%
5,731,244
-118,926
-2% -$7.72M
FAF icon
89
First American
FAF
$7.56B
$363M 0.38%
5,916,731
-216,863
-4% -$13.6M
COKE icon
90
Coca-Cola Consolidated
COKE
$12.7B
$357M 0.37%
2,329,643
+169,555
+8% +$24.9M
SGI
91
Somnigroup International
SGI
$14B
$355M 0.37%
3,974,443
-1,161,952
-23% -$102M
NTAP icon
92
NetApp
NTAP
$40.2B
$354M 0.37%
3,309,133
-8,472
-0.3% -$967K
EPAM icon
93
EPAM Systems
EPAM
$5.24B
$349M 0.36%
+1,704,768
New +$304M
PKG icon
94
Packaging Corp of America
PKG
$22.9B
$337M 0.35%
1,634,559
-29,911
-2% -$6.08M
FTDR icon
95
Frontdoor
FTDR
$5.83B
$334M 0.35%
5,777,252
+454,040
+9% +$26.7M
JNJ icon
96
Johnson & Johnson
JNJ
$632B
$328M 0.34%
1,584,129
-43,256
-3% -$8.55M
AMG icon
97
Affiliated Managers Group
AMG
$9.7B
$328M 0.34%
1,136,710
-20,634
-2% -$5.33M
CG icon
98
Carlyle Group
CG
$18.3B
$327M 0.34%
5,533,198
-636,926
-10% -$36.2M
J icon
99
Jacobs Solutions
J
$16.8B
$325M 0.34%
2,447,880
-592,503
-19% -$86.9M
SLB icon
100
SLB Ltd
SLB
$77.3B
$324M 0.34%
8,400,146
-389,489
-4% -$14.1M

Similar funds

Boston Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Boston Partners held 822 positions worth $96.6B, down 0.83% from $97.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Partners's Q4 2025 filing shows 68 new, 222 increased, 455 reduced and 69 closed positions. Its largest new stake was Meta Platforms (Facebook): 1,113,139 shares worth $733M. The largest sale was Alphabet (Google) Class A, an estimated $837M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

  • Boston Partners's largest Q4 2025 buy was Meta Platforms (Facebook): 1,113,139 shares worth $733M.
  • Boston Partners added most to Cigna in Q4 2025, an estimated $348M increase.
  • Boston Partners's biggest Q4 2025 reduction was Alphabet (Google) Class A, cutting an estimated $837M.
  • Boston Partners fully exited Harley-Davidson in Q4 2025, selling an estimated $112M.
  • Boston Partners's ten largest holdings make up 13% of its $96.6B portfolio in Q4 2025.
  • Boston Partners opened 68 new positions and closed 69 in Q4 2025.
  • Boston Partners's portfolio value fell 0.83% quarter-over-quarter to $96.6B.

Based on Boston Partners's 13F filing for Q4 2025, filed 13 Feb 2026.